Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP

Watchlist Manager
Tonix Pharmaceuticals Holding Corp Logo
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
Watchlist
Price: 40.45 USD 6.28% Market Closed
Market Cap: 296.1m USD

Wall Street
Price Targets

TNXP Price Targets Summary
Tonix Pharmaceuticals Holding Corp

There are no price targets for TNXP.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Tonix Pharmaceuticals Holding Corp Competitors:
Price Targets
688331
RemeGen Co Ltd
29% Downside
MAB
Mabion SA
1% Downside
VNDA
Vanda Pharmaceuticals Inc
194% Upside
BINV
BioInvent International AB
133% Upside
4974
Takara Bio Inc
62% Upside
688373
Shanghai MicuRx Pharmaceutical Co Ltd
17% Downside
GRAL
Grail Inc
17% Downside
301047
Sino Biological Inc
24% Upside

Revenue
Forecast

Revenue Estimate
Tonix Pharmaceuticals Holding Corp

The compound annual growth rate of Tonix Pharmaceuticals Holding Corp's revenue for the next 3 years is 137%.

N/A
Past Growth
137%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Tonix Pharmaceuticals Holding Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

Net Income Estimate
Tonix Pharmaceuticals Holding Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TNXP's stock price target?
Not Available

TNXP doesn't have any price targets made by Wall Street professionals.

What is Tonix Pharmaceuticals Holding Corp's Revenue forecast?
Projected CAGR
137%

The compound annual growth rate of Tonix Pharmaceuticals Holding Corp's revenue for the next 3 years is 137%.

Back to Top